New treatment option for Pleural Effusion
Official title Strategy for Prompt and Effective Thoracentesis in the Emergency Department
ClinicalTrials.gov ID: NCT06180603
What this study is testing
- What it's testing
- The SPEEDTAP-trial is a prospective, randomised, investigator-initiated, multicenter, clinical superior trial investigating two thoracentesis methods in four emergency departments (ED) in Central Denmark Region. Patients are randomised to either manual fluid removal in the ED or passively fluid drainage using gravity in the radiology department (standard of care).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients ≥ 18 years admitted to the ED
- Pleural effusion detected by any imaging modality (e.g., bedside ultrasound, chest x-ray, computed tomography)
- Clinically justified need for thoracentesis ( symptomatic relief and/or define the etiology of the effusion
- Without contraindication for thoracentesis in the emergency department (e.g., anticoagulant treatment)
You likely can't join if
- Life-threatening respiratory distress
- Not able to give consent
- Previous pleurodesis
- Effusion does not appear free-flowing due to septations or loculations / suspected empyema
- Prior enrollment in the trial
- If randomization is not possible because decision to insert a pigtail catheter is made in the radiology department
The study team makes the final eligibility decision.
Where it's taking place
- Aarhus, Central Jutland, Denmark
- Gødstrup, Central Jutland, Denmark
- Horsens, Central Jutland, Denmark
- Randers, Central Jutland, Denmark
- Aalborg, North Denmark, Denmark
- Esbjerg, South Region Denmark, Denmark
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Aarhus, Central Jutland, Denmark; Gødstrup, Central Jutland, Denmark; Horsens, Central Jutland, Denmark; Randers, Central Jutland, Denmark; Aalborg, North Denmark, Denmark; Esbjerg, South Region Denmark, Denmark. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.